91 related articles for article (PubMed ID: 19097781)
1. 1-Oxo-3-substitute-isothiochroman-4-carboxylic acid compounds: synthesis and biological activities of FAS inhibition.
Wang X; Zhao G; Chen Y; Xu X; Zhong W; Wang L; Li S
Bioorg Med Chem Lett; 2009 Feb; 19(3):770-2. PubMed ID: 19097781
[TBL] [Abstract][Full Text] [Related]
2. Beta-lactam congeners of orlistat as inhibitors of fatty acid synthase.
Zhang W; Richardson RD; Chamni S; Smith JW; Romo D
Bioorg Med Chem Lett; 2008 Apr; 18(7):2491-4. PubMed ID: 18343106
[TBL] [Abstract][Full Text] [Related]
3. Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.
Wang X; Lin J; Chen Y; Zhong W; Zhao G; Liu H; Li S; Wang L; Li S
Bioorg Med Chem; 2009 Mar; 17(5):1898-904. PubMed ID: 19223187
[TBL] [Abstract][Full Text] [Related]
4. Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.
McFadden JM; Medghalchi SM; Thupari JN; Pinn ML; Vadlamudi A; Miller KI; Kuhajda FP; Townsend CA
J Med Chem; 2005 Feb; 48(4):946-61. PubMed ID: 15715465
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat.
Pemble CW; Johnson LC; Kridel SJ; Lowther WT
Nat Struct Mol Biol; 2007 Aug; 14(8):704-9. PubMed ID: 17618296
[TBL] [Abstract][Full Text] [Related]
6. Peptides from purified soybean beta-conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain.
Martinez-Villaluenga C; Rupasinghe SG; Schuler MA; Gonzalez de Mejia E
FEBS J; 2010 Mar; 277(6):1481-93. PubMed ID: 20148945
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Block the FAS, lose the fat.
Mobbs CV; Makimura H
Nat Med; 2002 Apr; 8(4):335-6. PubMed ID: 11927935
[No Abstract] [Full Text] [Related]
9. Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase.
Ma G; Zancanella M; Oyola Y; Richardson RD; Smith JW; Romo D
Org Lett; 2006 Sep; 8(20):4497-500. PubMed ID: 16986934
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of enantiomeric pairs of 5-[(E)-cycloalk-2-enylidenemethyl]thiolactomycin congeners.
Ohata K; Terashima S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5598-600. PubMed ID: 18805004
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase inhibitory activity of acylphloroglucinols isolated from Dryopteris crassirhizoma.
Na M; Jang J; Min BS; Lee SJ; Lee MS; Kim BY; Oh WK; Ahn JS
Bioorg Med Chem Lett; 2006 Sep; 16(18):4738-42. PubMed ID: 16870425
[TBL] [Abstract][Full Text] [Related]
13. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
[TBL] [Abstract][Full Text] [Related]
14. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase inhibitors from the hulls of Nephelium lappaceum L.
Zhao YX; Liang WJ; Fan HJ; Ma QY; Tian WX; Dai HF; Jiang HZ; Li N; Ma XF
Carbohydr Res; 2011 Aug; 346(11):1302-6. PubMed ID: 21605850
[TBL] [Abstract][Full Text] [Related]
16. New substrates and inhibitors of gamma-aminobutyric acid aminotransferase containing bioisosteres of the carboxylic acid group: design, synthesis, and biological activity.
Yuan H; Silverman RB
Bioorg Med Chem; 2006 Mar; 14(5):1331-8. PubMed ID: 16263300
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of novel RXR antagonists: orally active anti-diabetic and anti-obesity agents.
Sakaki J; Kishida M; Konishi K; Gunji H; Toyao A; Matsumoto Y; Kanazawa T; Uchiyama H; Fukaya H; Mitani H; Arai Y; Kimura M
Bioorg Med Chem Lett; 2007 Sep; 17(17):4804-7. PubMed ID: 17651968
[TBL] [Abstract][Full Text] [Related]
18. Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors.
Zeng LF; Zhang HS; Wang YH; Sanchez T; Zheng YT; Neamati N; Long YQ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4521-4. PubMed ID: 18662877
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
[TBL] [Abstract][Full Text] [Related]
20. The connections between C75 and obesity drug-target pathways.
Kuhajda FP; Landree LE; Ronnett GV
Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
